Express Scripts Holding (Nasdaq: ESRX) is expected to report Q2 earnings on Aug. 7. Here's what Wall Street wants to see.

The 10-second takeaway
Comparing the upcoming quarter with the prior-year quarter, average analyst estimates predict Express Scripts Holding's revenues will grow 133.9% and EPS will grow 15.5%.

The average estimate for revenue is $26.57 billion. On the bottom line, the average EPS estimate is $0.82.

Revenue details
Last quarter, Express Scripts Holding reported revenue of $12.13 billion. GAAP reported sales were 9.4% higher than the prior-year quarter's $11.09 billion.

My

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.73. GAAP EPS of $0.55 for Q1 were 9.8% lower than the prior-year quarter's $0.61 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 6.9%, 20 basis points better than the prior-year quarter. Operating margin was 4.9%, 10 basis points worse than the prior-year quarter. Net margin was 2.2%, 70 basis points worse than the prior-year quarter.

Looking ahead
The full year's average estimate for revenue is $92.70 billion. The average EPS estimate is $3.54.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 714 members out of 759 rating the stock outperform, and 45 members rating it underperform. Among 183 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 172 give Express Scripts Holding a green thumbs-up, and 11 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Express Scripts Holding is outperform, with an average price target of $61.75.

The health-care investing landscape is littered with also-rans and a few major winners. Is Express Scripts Holding prepared for the future? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will deliver amazing returns during the next few years. Get instant access to this free report.